| aAPCs | Artificial antigen-presenting cells |
| ACE2 | Angiotensin Converting Enzyme 2 |
| Ad5 | Adenovirus 5 |
| ALT | Alanine aminotransferase |
| ARDS | Acute-respiratory disease syndrome |
| AST | Aspartate aminotransferase |
| AT1R | Angiotensin type-1 receptor |
| CAR | Chimeric antigen receptor |
| CEPI | Coalition for Epidemic Preparedness Innovations |
| cGAMP | Cyclic guanosine monophosphate–adenosine monophosphate |
| CoV | Coronavirus |
| COVID-19 | Coronavirus disease 2019 |
| CP | Convalescent plasma |
| CQ | Chloroquine |
| CRP | C reactive protein |
| CRS | Cytokine release syndrome |
| CTL | Cytotoxic T lymphocytes |
| DCs | Dendritic cells |
| ESR | Erythrocyte sedimentation rate |
| hAds | Human adenoviruses |
| HCQ | Hydroxychloroquine |
| HIV | Human Immunodeficiency Virus |
| IDV | Immune-derived vaccines |
| iPSC | Induced pluripotent stem cells |
| IVIgG | Intravenous Immunoglobulin G |
| LAMP | Loop-mediated isothermal amplification |
| LAV | Live attenuated vaccines |
| LDH | Lactate dehydrogenase |
| LMWH | Low molecular weight heparin |
| mAbs | Monoclonal antibodies |
| MDW | Monocyte volume distribution width |
| MERS | Middle East Respiratory Syndrome |
| MHC | Major Histocompatibility Complex |
| PRR | Pattern Recognition Receptors |
| PT | Prothrombin time |
| RAS | Renin–angiotensin system |
| RBD | Receptor binding domain |
| RdRp | RNA-dependent RNA polymerase |
| rRT-PCR | Reverse real-time PCR |
| SARS | Severe Acute Respiratory Syndrome |
| sdAb | Single-domain antibodies |
| siRNAs | Anti-sense RNA |
| TLR | Toll like receptor |
| tPA | Tissue plasminogen activator |
| VLP | Virus-like particles |